Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Psychiatric Clinics of North America|September 2, 2022
Substance Use Disorders in Postacute and Long-Term Care SettingsAbhilash Desai, George Grossberg
The Journal of ECT|November 26, 2009
Electroconvulsive therapy in the presence of a metallic skull plate after meningioma resectionTed Ling, Jothika Manepalli, George Grossberg
Drugs & Aging|June 24, 2025
Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence ShowsLou Vinarcsik, Charles Smoller, George Grossberg
The Journal of Nutrition, Health & Aging|January 11, 2025
Intermittent fasting and neurocognitive disorders: What the evidence showsJordan Beveridge, Allison Montgomery, George Grossberg
American Journal of Alzheimer'S Disease and Other Dementias|February 2, 2011
Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's diseaseGeorge Grossberg, Xiangyi Meng, Jason T Olin
CNS Drugs|August 21, 2023
Over the Counter Supplements for Memory: A Review of Available EvidenceHaley Hersant, Sean He, Peter Maliha, et al.
JAMA Neurology|April 1, 2024
Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A ReviewJeffrey Cummings, Krista Lanctot, George Grossberg, et al.
Substance Abuse and Rehabilitation|July 24, 2024
Prevalence and Treatment of Substance Misuse in Older Adults: Beyond Early AdulthoodJiahao Hu, Neha Kulkarni, Peter Maliha, et al.
The Journal of Frailty & Aging|May 24, 2025
A retrospective cohort study on the relationship between frailty and healthcare outcomesJinmyoung Cho, Joanne Salas, Jeffery F Scherrer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 14, 2004
Rivastigmine in Alzheimer disease: efficacy over two yearsGeorge Grossberg, Peter Irwin, Andrew Satlin, et al.
Pageof 4